Skip to content

Moderna to enter seasonal flu vaccine business

September 17, 2020

Ahead of today’s R&D Day event, expected to start at 8:00 am ET, Moderna (NASDAQ:MRNA) says it plans to enter the seasonal flu business for influenza types A&B.

On the COVID-19 front, its large-scale Phase 3 clinical trial evaluating mRNA-1273 has now enrolled 25,296 participants.

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: